Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2099PDF: 1942HTML: 146 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1629PDF: 628HTML: 2415 -
-
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1298PDF: 787HTML: 1001Untitled: 170 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3258PDF: 1213HTML: 2179 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2081PDF: 796HTML: 1629Figure 1: 196 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2992PDF: 845HTML: 7150Kost Fig1: 167Kost Fig 2: 159Kost Fig3: 155Kost Fig 4: 172Kost Fig5: 170Kost fig 6: 156 -
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3685PDF: 1426HTML: 465Figures . Eliassian: 207 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4341PDF: 1589HTML: 3439Tables and Images: 201 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1662PDF: 804HTML: 137 -
Severe Acute Hepatitis B Treated with Entecavir
1463PDF: 755HTML: 2458Figure: 154Title page: 160disclosure: 92 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
682PDF: 798PDF Supp. Files: 69HTML: 172 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6715PDF: 3582HTML: 731 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7292PDF: 2378HTML: 1708Table 1.: 190Table 2.: 204Table 3.: 185Table 4.: 182 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3831PDF: 3143HTML: 187 -
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
831PDF: 571HTML: 265 -
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1023PDF: 596Html: 136 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1219PDF: 904HTML: 83 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1561PDF: 963HTML: 347 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1206PDF: 634HTML: 7710 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2116PDF: 1753HTML: 128 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3457PDF: 2356HTML: 1412 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
790PDF: 788HTML: 98 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1818PDF: 668HTML: 224 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3924PDF: 1272HTML: 2243 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1635PDF: 1064HTML: 10688Untitled: 169 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1347PDF: 801HTML: 3104 -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3076PDF: 1261HTML: 13973jdoe, Dening.MarijuanaFi7.doc: 179jdoe, Dening.MarijuanaFi6.doc: 166jdoe, Dening.MarijuanaFi5.doc: 158jdoe, Dening.MarijuanaFi4.doc: 173jdoe, Dening.MarijuanaFi3.doc: 179jdoe, Dening.MarijuanaFi2.doc: 219jdoe, Dening.MarijuanaFig1.doc: 194







